Stock listing
NASDAQ:ACHN Achillion Pharmaceuticals Inc Stock
Follow Achillion Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ACHN
$6.76 USD
Close on Jan 27, 2020 · No longer trades
- Lowest – highest close
- $0.68 – $19.61 USDSince Oct 26, 2006 · lowest Dec 31, 2008 · highest Feb 1, 2007
Delisted NASDAQ:ACHN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ACHN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Achillion Pharmaceuticals Inc on 6ix
- Decks
- 2 decks · latest Nov 20, 2019
Where Achillion Pharmaceuticals Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ACHN · This page · Delisted | NASDAQ | United States | USD |
| OTC:ACHN · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (November 2019) | Merger or acquisition | 23 slides | Nov 20, 2019 |
| Technical Presentation (May 2019) | Technical | 33 slides | May 17, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Grey Other companies: OnKure Therapeutics, Inc. (Chairman · Since at least Apr 8, 2021); Spruce Biosciences, Inc. (Executive Chairman · Since at least Oct 8, 2020); Mirum Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2019); Horizon Pharma PLC (Director · Sep 29, 2011 – May 3, 2018 · Past); BioMarin Pharmaceutical Inc. (Director · Dec 14, 2006 – Mar 5, 2021 · Past); Idm Pharma Inc (Director · Jun 14, 2006 – Dec 11, 2008 · Past); SGX Pharmaceuticals Inc (President & CEO, Director · Jan 31, 2006 – Aug 20, 2008 · Past) | Director · Oct 25, 2006 – Dec 18, 2009 · Past |
| Mary Kay Fenton Other companies: Cullinan Therapeutics, Inc. (Chief Financial Officer · Since at least Apr 29, 2024); Tourmaline Bio Inc. (Chief Financial Officer · May 6, 2021 – Jul 3, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past) | Chief Financial Officer · Dec 12, 2011 – Feb 9, 2018 · Past |
| Kurt Graves Other companies: Seres Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Radius Health, Inc. (Director · Feb 13, 2018 – Feb 20, 2020 · Past) | Director · Feb 9, 2018 – Jan 28, 2020 · Past |
| Michael D Kishbauch Other companies: Astria Therapeutics Inc (Director · Since at least Apr 5, 2016); Progenics Pharmaceuticals Inc (Director · Jun 8, 2016 – Jul 11, 2019 · Past) | Director · Jan 25, 2016 – Jan 28, 2020 · Past |
| Nicholas Simon Other companies: Gritstone bio, Inc. (Director · Sep 27, 2018 – Jun 18, 2020 · Past); Sientra Inc (Director · Oct 28, 2014 – Jun 10, 2021 · Past) | Director · Aug 20, 2010 – Jun 4, 2012 · Past |
| Elizabeth A Olek Other companies: Kronos Bio Inc (SR VP, CLINICAL SCIENCE · Feb 16, 2024 – Feb 21, 2024 · Past) | SVP and CMO · Dec 15, 2008 – Jan 10, 2012 · Past |
| Frank Verwiel Other companies: Intellia Therapeutics, Inc. (Director · Since at least May 21, 2019) | Director · Jan 28, 2020 – Jan 28, 2020 · Past |
| Paul E Firuta Other companies: uniQure N.V. (Chief Commercial Officer · Dec 13, 2017 – Jan 26, 2018 · Past) | EVP, Chief Commercial Officer · Sep 10, 2018 – Jan 28, 2020 · Past |
| David Scheer | Director · Nov 13, 2019 – Jan 28, 2020 · Past |
Log in to ask 6ix AI your own questions about Achillion Pharmaceuticals Inc.